1
|
Rickert CA, Mansi S, Fan D, Mela P, Lieleg O. A Mucin-Based Bio-Ink for 3D Printing of Objects with Anti-Biofouling Properties. Macromol Biosci 2023; 23:e2300198. [PMID: 37466113 DOI: 10.1002/mabi.202300198] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 07/10/2023] [Accepted: 07/16/2023] [Indexed: 07/20/2023]
Abstract
With its potential to revolutionize the field of personalized medicine by producing customized medical devices and constructs for tissue engineering at low costs, 3D printing has emerged as a highly promising technology. Recent advancements have sparked increasing interest in the printing of biopolymeric hydrogels. However, owing to the limited printability of those soft materials, the lack of variability in available bio-inks remains a major challenge. In this study, a novel bio-ink is developed based on functionalized mucin-a glycoprotein that exhibits a multitude of biomedically interesting properties such as immunomodulating activity and strong anti-biofouling behavior. To achieve sufficient printability of the mucin-based ink, its rheological properties are tuned by incorporating Laponite XLG as a stabilizing agent. It is shown that cured objects generated from this novel bio-ink exhibit mechanical properties partially similar to that of soft tissue, show strong anti-biofouling properties, good biocompatibility, tunable cell adhesion, and immunomodulating behavior. The presented findings suggest that this 3D printable bio-ink has a great potential for a wide range of biomedical applications, including tissue engineering, wound healing, and soft robotics.
Collapse
Affiliation(s)
- Carolin A Rickert
- TUM School of Engineering and Design, Department of Materials Engineering, Technical University of Munich, Boltzmannstr. 15, 85748, Garching b. München, Germany
- Center for Functional Protein Assemblies (CPA), Technical University of Munich, Ernst-Otto-Fischer Str. 8, 85748, Garching b. München, Germany
| | - Salma Mansi
- TUM School of Engineering and Design, Department of Mechanical Engineering, Chair of Medical Materials and Implants, Technical University of Munich, Boltzmannstr. 15, 85748, Garching b. München, Germany
- Munich Institute of Biomedical Engineering and Munich Institute of Integrated Materials, Energy and Process Engineering, Technical University of Munich, Boltzmannstr. 15, 85748, Garching, Germany
| | - Di Fan
- TUM School of Engineering and Design, Department of Materials Engineering, Technical University of Munich, Boltzmannstr. 15, 85748, Garching b. München, Germany
- Center for Functional Protein Assemblies (CPA), Technical University of Munich, Ernst-Otto-Fischer Str. 8, 85748, Garching b. München, Germany
| | - Petra Mela
- TUM School of Engineering and Design, Department of Mechanical Engineering, Chair of Medical Materials and Implants, Technical University of Munich, Boltzmannstr. 15, 85748, Garching b. München, Germany
- Munich Institute of Biomedical Engineering and Munich Institute of Integrated Materials, Energy and Process Engineering, Technical University of Munich, Boltzmannstr. 15, 85748, Garching, Germany
| | - Oliver Lieleg
- TUM School of Engineering and Design, Department of Materials Engineering, Technical University of Munich, Boltzmannstr. 15, 85748, Garching b. München, Germany
- Center for Functional Protein Assemblies (CPA), Technical University of Munich, Ernst-Otto-Fischer Str. 8, 85748, Garching b. München, Germany
| |
Collapse
|
2
|
Barbosa RDM, Leite AM, García-Villén F, Sánchez-Espejo R, Cerezo P, Viseras C, Faccendini A, Sandri G, Raffin FN, Moura TFADLE. Hybrid Lipid/Clay Carrier Systems Containing Annatto Oil for Topical Formulations. Pharmaceutics 2022; 14:pharmaceutics14051067. [PMID: 35631653 PMCID: PMC9147908 DOI: 10.3390/pharmaceutics14051067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 04/15/2022] [Accepted: 04/26/2022] [Indexed: 12/10/2022] Open
Abstract
Nanocomposites formed by clay and lipid carriers (NLCs) show a high potential for providing controlled release and specific delivery of bioactive molecules and have recently gained attention in the pharmaceutical sector due to their ability to transport hydrophilic and hydrophobic drugs. Recent studies have recognized the biological activity of the oil of Bixa orellana L. (AO) with regards to its healing, antioxidant, antibacterial, and anti-leishmanial properties. Therefore, the purpose of this study is the preparation and characterization of hybrid systems based on lipid nanocarriers and laponite for the delivery of AO. NLCs were prepared by the fusion-emulsification method, using cetyl palmitate (CP) or myristyl myristate (MM), AO, and Poloxamer 188. The morphology, hydrodynamic diameters, zeta potential (ZP), polydispersity index (PDI), thermal analysis, X-ray diffraction analysis (XRD), viscosity behavior, and cytotoxicity testing of the hybrid systems were performed. The thermal study and X-ray diffraction analyses (XRD) revealed polymorphic structural changes compatible with the amorphization of the material. Rheological assays highlighted a typical pseudoplastic behavior in all systems (MM and CP with LAP). The hybrid systems’ morphology, size diameters, and PDIs were similar, preset spherical and monodisperse structures (≈200 nm; <0.3), without significant change up to sixty days. The ZP values differed from each other, becoming higher with increasing AO concentration. XEDS spectra and elemental X-ray maps show peaks of lipids (organic components, C and O) and inorganic components O, Mg, and Si. All samples showed cell viability above 60%. The results indicated a stable, biocompatible hybrid system that can be an alternative for topical application.
Collapse
Affiliation(s)
- Raquel de Melo Barbosa
- Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil; (A.M.L.); (T.F.A.d.L.e.M.)
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain; (F.G.-V.); (R.S.-E.); (P.C.); (C.V.)
- Correspondence: (R.d.M.B.); (F.N.R.)
| | - Aliana Monteiro Leite
- Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil; (A.M.L.); (T.F.A.d.L.e.M.)
| | - Fátima García-Villén
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain; (F.G.-V.); (R.S.-E.); (P.C.); (C.V.)
| | - Rita Sánchez-Espejo
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain; (F.G.-V.); (R.S.-E.); (P.C.); (C.V.)
| | - Pilar Cerezo
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain; (F.G.-V.); (R.S.-E.); (P.C.); (C.V.)
| | - César Viseras
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja s/n, 18071 Granada, Spain; (F.G.-V.); (R.S.-E.); (P.C.); (C.V.)
- Andalusian Institute of Earth Sciences, CSIC-University of Granada, Av. de las Palmeras 4, Armilla, 18100 Granada, Spain
| | - Angela Faccendini
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (A.F.); (G.S.)
| | - Giuseppina Sandri
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (A.F.); (G.S.)
| | - Fernanda Nervo Raffin
- Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil; (A.M.L.); (T.F.A.d.L.e.M.)
- Correspondence: (R.d.M.B.); (F.N.R.)
| | - Túlio Flávio Accioly de Lima e Moura
- Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil; (A.M.L.); (T.F.A.d.L.e.M.)
| |
Collapse
|
3
|
Teng L, Xia K, Qian T, Hu Z, Hong L, Liao Y, Peng G, Yuan Z, Chen Y, Zeng Z. Shape-Recoverable Macroporous Nanocomposite Hydrogels Created via Ice Templating Polymerization for Noncompressible Wound Hemorrhage. ACS Biomater Sci Eng 2022; 8:2076-2087. [PMID: 35426307 DOI: 10.1021/acsbiomaterials.2c00115] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Uncontrolled hemorrhage resulting from severe trauma or surgical operations remains a challenge. It is highly important to develop functional materials to treat noncompressible wound bleeding. In this work, a shape-recoverable macroporous nanocomposite hydrogel was facilely created through ice templating polymerization. The covalently cross-linked gelatin networks provide a robust framework, while the Laponite nanoclay disperses into the three-dimensional matrix, enabling mechanical reinforcement and hemostatic functions. The resultant macroporous nanocomposite hydrogel possesses an inherent interconnected macroporous structure and rapid deformation recovery. In vitro assessments indicate that the hydrogel displays good cytocompatibility and a low hemolysis ratio. The hydrogel shows a higher coagulation potential and more erythrocyte adhesion compared to the commercial gauze and gelatin sponge. The noncompressible liver hemorrhage models also confirm its promising hemostasis performance. This strategy of combining a nano-enabled solution with ice templating polymerization displays great potential to develop appealing absorbable macroporous biomaterials for rapid hemostasis.
Collapse
Affiliation(s)
- Lijing Teng
- Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, School of Biology and Engineering, Guizhou Medical University, Guiyang 550025, China
| | - Kaide Xia
- School of Basic Medical Sciences, Guizhou Medical University, Maternal and Child Health Care Hospital, Guiyang Children's Hospital, Guiyang 550025, China
| | - Tianbao Qian
- School of Biology and Engineering, Guizhou Medical University, Guiyang 550025, China
| | - Zuquan Hu
- Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, School of Biology and Engineering, Guizhou Medical University, Guiyang 550025, China
| | - Liang Hong
- School of Biology and Engineering, Guizhou Medical University, Guiyang 550025, China
| | - Ying Liao
- School of Biology and Engineering, Guizhou Medical University, Guiyang 550025, China
| | - Guorui Peng
- School of Anesthesiology, Guizhou Medical University, Guiyang 550025, China
| | - Zhongrun Yuan
- School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China
| | - Yunhua Chen
- School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China
| | - Zhu Zeng
- Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China
| |
Collapse
|